Affiance Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.28M | Sell |
1,636
-11
| -0.7% | -$8.58K | 0.26% | 44 |
|
2025
Q1 | $1.36M | Sell |
1,647
-6
| -0.4% | -$4.96K | 0.32% | 42 |
|
2024
Q4 | $1.28M | Sell |
1,653
-272
| -14% | -$210K | 0.31% | 46 |
|
2024
Q3 | $1.71M | Hold |
1,925
| – | – | 0.41% | 37 |
|
2024
Q2 | $1.74M | Buy |
1,925
+85
| +5% | +$77K | 0.45% | 34 |
|
2024
Q1 | $1.43M | Buy |
1,840
+5
| +0.3% | +$3.89K | 0.39% | 38 |
|
2023
Q4 | $1.07M | Hold |
1,835
| – | – | 0.31% | 50 |
|
2023
Q3 | $986K | Hold |
1,835
| – | – | 0.5% | 48 |
|
2023
Q2 | $861K | Hold |
1,835
| – | – | 0.42% | 53 |
|
2023
Q1 | $630K | Hold |
1,835
| – | – | 0.33% | 56 |
|
2022
Q4 | $671K | Hold |
1,835
| – | – | 0.27% | 60 |
|
2022
Q3 | $593K | Hold |
1,835
| – | – | 0.33% | 42 |
|
2022
Q2 | $595K | Hold |
1,835
| – | – | 0.32% | 47 |
|
2022
Q1 | $525K | Buy |
1,835
+35
| +2% | +$10K | 0.26% | 56 |
|
2021
Q4 | $497K | Hold |
1,800
| – | – | 0.21% | 74 |
|
2021
Q3 | $416K | Sell |
1,800
-5
| -0.3% | -$1.16K | 0.18% | 80 |
|
2021
Q2 | $414K | Buy |
1,805
+5
| +0.3% | +$1.15K | 0.18% | 81 |
|
2021
Q1 | $336K | Hold |
1,800
| – | – | 0.15% | 85 |
|
2020
Q4 | $304K | Hold |
1,800
| – | – | 0.16% | 86 |
|
2020
Q3 | $266K | Hold |
1,800
| – | – | 0.15% | 85 |
|
2020
Q2 | $296K | Hold |
1,800
| – | – | 0.16% | 74 |
|
2020
Q1 | $250K | Hold |
1,800
| – | – | 0.17% | 72 |
|
2019
Q4 | $237K | Hold |
1,800
| – | – | 0.13% | 81 |
|
2019
Q3 | $201K | Buy |
+1,800
| New | +$201K | 0.12% | 90 |
|
2019
Q2 | – | Sell |
-1,800
| Closed | -$234K | – | 93 |
|
2019
Q1 | $234K | Hold |
1,800
| – | – | 0.15% | 84 |
|
2018
Q4 | $208K | Buy |
+1,800
| New | +$208K | 0.14% | 89 |
|